ISPOR - PHP23 The Early Benefit Assessment of New Pharmaceuticals in Germany (“AMNOG”)- A Structured Survey Analysis One Year After Enactment

Full Text

PHP23 The Early Benefit Assessment of New Pharmaceuticals in Germany (“AMNOG”)- A Structured Survey Analysis One Year After Enactment

Abstract

Authors

F. Stoeckel A.S. Neubauer

Back to Volume 15, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now